Page last updated: 2024-12-07

4-o-methyl-phorbol-12,13-didecanoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

4-O-methyl-phorbol-12,13-didecanoate (PMA) is a potent tumor promoter, a member of the phorbol ester family. It is commonly used in research to activate protein kinase C (PKC), a key signaling enzyme involved in cell growth and differentiation. PMA's effects are attributed to its ability to bind to and activate PKC, leading to a cascade of downstream events, including the activation of transcription factors and the production of inflammatory mediators. PMA is synthesized from phorbol, a diterpene compound extracted from the plant Croton tiglium. Its synthesis involves multiple steps, including esterification and methylation reactions. The potent biological activity of PMA, its ability to activate PKC, and its role in tumor promotion make it a valuable tool for studying signal transduction pathways and the development of cancer. PMA is also used as a research tool to study the role of PKC in various cellular processes, including inflammation, immune responses, and apoptosis. Due to its potent activity and its ability to mimic the effects of tumor promoters, PMA is widely used in research to study the molecular mechanisms of cancer development.'

Cross-References

ID SourceID
PubMed CID119493
MeSH IDM0071960

Synonyms (8)

Synonym
54870-24-5
4-o-mepdd
4-o-methyl-phorbol-12,13-didecanoate
5h-cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-7b-alpha,9-beta,9a-alpha-trihydroxy-3-hydroxymethyl-1,1,6,8-alpha-tetramethyl-4a-methoxy-, 9,9a-didecanoate
decanoic acid, 1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-7b-hydroxy-3-(hydroxymethyl)-4a-methoxy-1,1,6,8-tetramethyl-5-oxo-9ah-cyclopropa(3,4)benz(1,2-e)azulene-9,9a-diyl ester, (1ar-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha))-
7b-hydroxy-3-(hydroxymethyl)-4a-methoxy-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9ah-cyclopropa[3,4]benzo[1,2-e]azulene-9,9a-diyl didecanoate
DTXSID60970210
[(1s,2s,6r,10s,11r,13s,14r,15r)-13-decanoyloxy-1-hydroxy-8-(hydroxymethyl)-6-methoxy-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] decanoate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.53 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]